Cross-Sectional (n=154)
No
Answers are grounded in this paper and cite their sources.
NT-proBNP levels correlate with physical symptom severity, LVEF, and comorbidities in patients with heart failure, supporting individualized treatment based on severity.
PURPOSE: This study aimed to examine the relationships between the N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels with the sociodemographic and clinical factors, self-care behaviors, and the physical symptom experiences in patients with heart failure.METHODS: This cross-sectional study utilized a convenience sample of adult outpatients and inpatients who attended a cardiology department in a tertiary hospital in Seoul, Korea. The data from 154 patients with heart failure were collected using a questionnaire, and their clinical data were extracted from their electronic medical records.RESULTS: Compared with the patients with high NT-proBNP levels, those with low NT-proBNP levels had significantly lower physical symptom experiences scores. Patients with low- and mid-NT-proBNP levels were more likely to be employed compared with those with high NT-proBNP levels. Patients with low NT-proBNP levels had higher left ventricular ejection fractions, and were less likely to have arrhythmias and comorbidities.CONCLUSION: The results from this study showed that patients with more severe heart failure had higher physical symptom experiences scores; hence, individualizing treatment approaches based on heart failure severity is necessary.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2016) conducted a cross-sectional in Heart failure (n=154). NT-proBNP levels vs. Low and mid NT-proBNP levels was evaluated on Physical symptom experiences scores, sociodemographic and clinical factors.
Synapse has enriched 10 related papers. Consider them for comparative context: